Abnormal Elevation of Serum ALT Level Induced by Multiple Administrations of Unfractionated Heparin in Healthy Japanese Volunteers

Akinori Urae, Mitsuko Okada, Kenichi Inada, Midori Kotake, Takanori Tanaka, Shin Irie, Toru Maruyama, Shigeyuki Nakano, Masayuki Hashiguchi

Research output: Contribution to journalArticle

Abstract

Objective: Although often described abroad, heparin-induced hepatotoxicity is seldom recognized in clinical practice in Japan. We evaluated the safety of multiple doses of unfractionated heparin using healthy Japanese volunteers, with the primary focus on serum transaminase levels. Methods: Eight healthy males, aged between 20 and 24 years, participated in the study. Six of the 8 volunteers received subcutaneous administration of 5000 IU unfractionated calcium heparin (UFH) for 9 days. The remaining two volunteers received subcutaneous saline injections in place of UFH. A follow-up survey was conducted for 7 days following the final administration. Laboratory measurements, including the levels of hepatic enzymes, were taken during the administration of UFH. Results: Administration of UFH to five of the six volunteers had to be stopped within the first week. Administration in one subject was discontinued on day 3 due to prolonged activated partial thromboplastin time; the other four were due to an abnormal elevation of ALT above the level considered to be safe. This abnormal elevation continued for 2 days, despite cessation of administration. The levels then gradually decreased, and within 6 weeks returned to pre-administration levels. Conclusion: An abnormal elevation of transaminase levels following repeated injections of UFH was observed in Japanese as is reported in Caucasians. As we have shown, it is highly probable that this abnormal elevation of transaminase levels, during repeated administration of UFH, could be observed in the clinical setting in Japan. Monitoring of serum transaminase levels at periodic intervals should thus be encouraged during multiple injections of UFH even though clinically relevant symptoms may not be noticed.

Original languageEnglish
Pages (from-to)97-103
Number of pages7
JournalJapanese Journal of Clinical Pharmacology and Therapeutics
Volume35
Issue number2
DOIs
Publication statusPublished - Jan 1 2004

Fingerprint

Heparin
Healthy Volunteers
Serum
Transaminases
Volunteers
Japan
Injections
Partial Thromboplastin Time
Subcutaneous Injections
calcium heparin
Safety
Liver
Enzymes

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this

Abnormal Elevation of Serum ALT Level Induced by Multiple Administrations of Unfractionated Heparin in Healthy Japanese Volunteers. / Urae, Akinori; Okada, Mitsuko; Inada, Kenichi; Kotake, Midori; Tanaka, Takanori; Irie, Shin; Maruyama, Toru; Nakano, Shigeyuki; Hashiguchi, Masayuki.

In: Japanese Journal of Clinical Pharmacology and Therapeutics, Vol. 35, No. 2, 01.01.2004, p. 97-103.

Research output: Contribution to journalArticle

Urae, Akinori ; Okada, Mitsuko ; Inada, Kenichi ; Kotake, Midori ; Tanaka, Takanori ; Irie, Shin ; Maruyama, Toru ; Nakano, Shigeyuki ; Hashiguchi, Masayuki. / Abnormal Elevation of Serum ALT Level Induced by Multiple Administrations of Unfractionated Heparin in Healthy Japanese Volunteers. In: Japanese Journal of Clinical Pharmacology and Therapeutics. 2004 ; Vol. 35, No. 2. pp. 97-103.
@article{27c3d436fdb64b769e0ceedc5a910194,
title = "Abnormal Elevation of Serum ALT Level Induced by Multiple Administrations of Unfractionated Heparin in Healthy Japanese Volunteers",
abstract = "Objective: Although often described abroad, heparin-induced hepatotoxicity is seldom recognized in clinical practice in Japan. We evaluated the safety of multiple doses of unfractionated heparin using healthy Japanese volunteers, with the primary focus on serum transaminase levels. Methods: Eight healthy males, aged between 20 and 24 years, participated in the study. Six of the 8 volunteers received subcutaneous administration of 5000 IU unfractionated calcium heparin (UFH) for 9 days. The remaining two volunteers received subcutaneous saline injections in place of UFH. A follow-up survey was conducted for 7 days following the final administration. Laboratory measurements, including the levels of hepatic enzymes, were taken during the administration of UFH. Results: Administration of UFH to five of the six volunteers had to be stopped within the first week. Administration in one subject was discontinued on day 3 due to prolonged activated partial thromboplastin time; the other four were due to an abnormal elevation of ALT above the level considered to be safe. This abnormal elevation continued for 2 days, despite cessation of administration. The levels then gradually decreased, and within 6 weeks returned to pre-administration levels. Conclusion: An abnormal elevation of transaminase levels following repeated injections of UFH was observed in Japanese as is reported in Caucasians. As we have shown, it is highly probable that this abnormal elevation of transaminase levels, during repeated administration of UFH, could be observed in the clinical setting in Japan. Monitoring of serum transaminase levels at periodic intervals should thus be encouraged during multiple injections of UFH even though clinically relevant symptoms may not be noticed.",
author = "Akinori Urae and Mitsuko Okada and Kenichi Inada and Midori Kotake and Takanori Tanaka and Shin Irie and Toru Maruyama and Shigeyuki Nakano and Masayuki Hashiguchi",
year = "2004",
month = "1",
day = "1",
doi = "10.3999/jscpt.35.2_97",
language = "English",
volume = "35",
pages = "97--103",
journal = "Japanese Journal of Clinical Pharmacology and Therapeutics",
issn = "0388-1601",
publisher = "Japanese Society of Clinical Pharmacology and Therapeutics",
number = "2",

}

TY - JOUR

T1 - Abnormal Elevation of Serum ALT Level Induced by Multiple Administrations of Unfractionated Heparin in Healthy Japanese Volunteers

AU - Urae, Akinori

AU - Okada, Mitsuko

AU - Inada, Kenichi

AU - Kotake, Midori

AU - Tanaka, Takanori

AU - Irie, Shin

AU - Maruyama, Toru

AU - Nakano, Shigeyuki

AU - Hashiguchi, Masayuki

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Objective: Although often described abroad, heparin-induced hepatotoxicity is seldom recognized in clinical practice in Japan. We evaluated the safety of multiple doses of unfractionated heparin using healthy Japanese volunteers, with the primary focus on serum transaminase levels. Methods: Eight healthy males, aged between 20 and 24 years, participated in the study. Six of the 8 volunteers received subcutaneous administration of 5000 IU unfractionated calcium heparin (UFH) for 9 days. The remaining two volunteers received subcutaneous saline injections in place of UFH. A follow-up survey was conducted for 7 days following the final administration. Laboratory measurements, including the levels of hepatic enzymes, were taken during the administration of UFH. Results: Administration of UFH to five of the six volunteers had to be stopped within the first week. Administration in one subject was discontinued on day 3 due to prolonged activated partial thromboplastin time; the other four were due to an abnormal elevation of ALT above the level considered to be safe. This abnormal elevation continued for 2 days, despite cessation of administration. The levels then gradually decreased, and within 6 weeks returned to pre-administration levels. Conclusion: An abnormal elevation of transaminase levels following repeated injections of UFH was observed in Japanese as is reported in Caucasians. As we have shown, it is highly probable that this abnormal elevation of transaminase levels, during repeated administration of UFH, could be observed in the clinical setting in Japan. Monitoring of serum transaminase levels at periodic intervals should thus be encouraged during multiple injections of UFH even though clinically relevant symptoms may not be noticed.

AB - Objective: Although often described abroad, heparin-induced hepatotoxicity is seldom recognized in clinical practice in Japan. We evaluated the safety of multiple doses of unfractionated heparin using healthy Japanese volunteers, with the primary focus on serum transaminase levels. Methods: Eight healthy males, aged between 20 and 24 years, participated in the study. Six of the 8 volunteers received subcutaneous administration of 5000 IU unfractionated calcium heparin (UFH) for 9 days. The remaining two volunteers received subcutaneous saline injections in place of UFH. A follow-up survey was conducted for 7 days following the final administration. Laboratory measurements, including the levels of hepatic enzymes, were taken during the administration of UFH. Results: Administration of UFH to five of the six volunteers had to be stopped within the first week. Administration in one subject was discontinued on day 3 due to prolonged activated partial thromboplastin time; the other four were due to an abnormal elevation of ALT above the level considered to be safe. This abnormal elevation continued for 2 days, despite cessation of administration. The levels then gradually decreased, and within 6 weeks returned to pre-administration levels. Conclusion: An abnormal elevation of transaminase levels following repeated injections of UFH was observed in Japanese as is reported in Caucasians. As we have shown, it is highly probable that this abnormal elevation of transaminase levels, during repeated administration of UFH, could be observed in the clinical setting in Japan. Monitoring of serum transaminase levels at periodic intervals should thus be encouraged during multiple injections of UFH even though clinically relevant symptoms may not be noticed.

UR - http://www.scopus.com/inward/record.url?scp=1942422102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1942422102&partnerID=8YFLogxK

U2 - 10.3999/jscpt.35.2_97

DO - 10.3999/jscpt.35.2_97

M3 - Article

VL - 35

SP - 97

EP - 103

JO - Japanese Journal of Clinical Pharmacology and Therapeutics

JF - Japanese Journal of Clinical Pharmacology and Therapeutics

SN - 0388-1601

IS - 2

ER -